跳至主要内容
临床试验/NL-OMON43537
NL-OMON43537撤回3 期

Improving quality of survivorship for breast cancer-related lymphedema by lymphatic microsurgery: A randomized controlled trial - BCRL-LVA study

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
撤回
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Woman over 18 years old
  • - Treated for early stage breast cancer and underwent an SLNB, ALND or axillary radiotherapy
  • - Early stage lymphedema of the arm (stage 1 -- 2b on ISL classification) with viable lymphatic vessels as determined by nearly infrared imaging
  • - Excess limb volume >=10%
  • - Followed three months conservative therapy (standard of care) according to best available care, this will be judged by skin therapists in our region
  • - Primary breast cancer
  • - Unilateral disease / treatment

排除标准

  • - Male sex
  • - Stage 3 lymphedema of the arm with evident fat deposition and/or fibrosis
  • - History of earlier lymph reconstruction efforts
  • - Recurrent breast cancer
  • - Distant breast cancer metastases
  • - Bilateral disease / treatment
  • - Medical history of cancer
  • - Primary congenital lymphedema
  • - Non-viable lymphatic system as determined by lymphoscintigraphy at inclusion

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验